Cambridge Investment Research Advisors, Inc. Gamida Cell Ltd. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $26 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.25 - $1.02 $8,750 - $35,700
35,000 Added 93.15%
72,575 $30,000
Q3 2023

Oct 24, 2023
BUY
$0.85 - $1.87 $2,975 - $6,545
3,500 Added 10.27%
37,575 $39,000
Q2 2023

Jul 13, 2023
BUY
$0.73 - $2.37 $10,950 - $35,550
15,000 Added 78.64%
34,075 $66,000
Q4 2022

Feb 08, 2023
BUY
$1.15 - $2.1 $21,936 - $40,057
19,075 New
19,075 $25,000

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email